MAM
Madison to handle CCD’s media account
Mumbai: Café Coffee Day (CCD) has awarded its media mandate to Madison Media for its chain of coffee Cafés.
The account size is estimated to be around Rs 400 million and will be handled by Madison Media Omega in Bangalore.
Madison Media Group CEO Gautam Kiyawat said, “We are delighted to have India’s premier and leading café chain, Café Coffee Day, to our roster of clients and are confident of helping it grow and gain further market share in the country.”
CCD president marketing K. Ramakrishnan said, “Café Coffee Day being a brand for the young and the young at heart, we needed a partner who would be passionate about the brand, to be able to understand the category in depth and the varying dynamics to enable us to move along at a fast pace. We are confident of Madison Media’s thought leadership and competence in executing the campaigns. We are delighted to have them on board”.
Café Coffee Day as a brand has never advertised in mass media in the last 16 years of its existence. It has been built on different marketing initiatives, coffee category building activities, public relations and social media.
The brand has just launched its first ever television commercial titled ‘Sit Down’ that has been created by Creativeland Asia.
For the record, Madison Media Group handles media mandate for clients including Airtel, Godrej, Cadbury/Kraft, ITC, General Motors, Marico and McDonald’s.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
